“Since our last press conference on Friday, several more countries have suspended the use of AstraZeneca vaccines as a precautionary measure after reports of blood clots in people who had received the vaccine from two batches produced in Europe. This does not necessarily mean these events are linked to vaccination. But it’s routine practice to investigate them, and it shows that the surveillance system works and that effective controls are in place.” “So far it doesn’t look like it’s — there are more cases than would be expected for the period in the general population, you know, because people get sick or people die all the time. In what we have seen so far from the preliminary data, it — there is not an increasing number of cases of thromboembolic events in, for example, in Europe. In the U.K., only more than 17 million doses of AstraZeneca vaccines were administered so far.”